Correspondence 0001493152-25-006307 from Indaptus Therapeutics, Inc. (INDP)
Indaptus Therapeutics, Inc.
Date: Feb. 13, 2025 · CIK: 0001857044 · Accession: 0001493152-25-006307
AI Filing Summary & Sentiment
File numbers found in text: 333-284863
Show Raw Text
CORRESP
1
filename1.htm
Indaptus
Therapeutics, Inc.
3
Columbus Circle
15th
Floor
New
York, NY 10019
February
13, 2025
VIA
EDGAR
Securities
and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
DC 20549
RE:
Indaptus
Therapeutics, Inc.
(CIK
0001857044)
Registration
Statement No. 333-284863 on Form S-1 (the “Registration Statement”)
Ladies
and Gentlemen:
Indaptus
Therapeutics, Inc. (the “Registrant”) hereby requests acceleration of the effectiveness of the above-referenced Registration
Statement pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), so that it may
become effective on February 13, 2025, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable.
The
undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel,
Greenberg Traurig, P.A., by calling Gary Emmanuel at 212-801-9337. The Company hereby authorizes Mr. Emmanuel to orally modify or withdraw
this request for acceleration.
Very
truly yours,
INDAPTUS
THERAPEUTICS, INC.
By:
/s/
Nir Sassi
Nir Sassi
Chief
Financial Officer